Holuka Eugene Myron
SEC CIK 1678292 · EDGAR
Most active insiders at CTOR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| No open-market trades in the last year. | ||||
Holuka Eugene Myron made no open-market trades at CTOR in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2025-12-22 | 2025-09-19 | CTOR | CITIUS ONCOLOGY, INC. | Holuka Eugene Myron | Dir | A - Grant | $0.00 | +300.0K | 300.0K | New | $0 |
| A | 2025-12-01 | 2025-09-19 | CTOR | CITIUS ONCOLOGY, INC. | Holuka Eugene Myron | Dir | A - Grant | $0.00 | +300.0K | 300.0K | New | $0 |
| 2025-09-23 | 2025-09-19 | CTOR | CITIUS ONCOLOGY, INC. | Holuka Eugene Myron | Dir | A - Grant | $0.00 | +300.0K | 300.0K | New | $0 | |
| D | 2024-08-30 | 2024-03-13 | CTXR | Citius Pharmaceuticals, Inc. | Holuka Eugene Myron | Dir | M - OptEx | $0.02 | +2,415 | 2,415 | New | +$48.30 |
| D | 2024-08-30 | 2024-03-13 | CTXR | Citius Pharmaceuticals, Inc. | Holuka Eugene Myron | Dir | F - Tax | $0.75 | -48 | 2,367 | -2% | -$36 |
Purchase Sale Sale after option exercise All abbreviations